SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-21-003815
Filing Date
2021-03-31
Accepted
2021-03-31 16:03:13
Documents
126
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K fbio-20201231x10k.htm   iXBRL 10-K 5111383
2 EX-4.3 fbio-20201231xex4d3.htm EX-4.3 96334
3 EX-21.1 fbio-20201231xex21d1.htm EX-21.1 13687
4 EX-23.1 fbio-20201231xex23d1.htm EX-23.1 6676
5 EX-31.1 fbio-20201231xex31d1.htm EX-31.1 15202
6 EX-31.2 fbio-20201231xex31d2.htm EX-31.2 14998
7 EX-32.1 fbio-20201231xex32d1.htm EX-32.1 7590
8 EX-32.2 fbio-20201231xex32d2.htm EX-32.2 7528
  Complete submission text file 0001558370-21-003815.txt   22328325

Data Files

Seq Description Document Type Size
9 EX-101.SCH fbio-20201231.xsd EX-101.SCH 158435
10 EX-101.CAL fbio-20201231_cal.xml EX-101.CAL 117360
11 EX-101.DEF fbio-20201231_def.xml EX-101.DEF 708178
12 EX-101.LAB fbio-20201231_lab.xml EX-101.LAB 1019896
13 EX-101.PRE fbio-20201231_pre.xml EX-101.PRE 1079851
14 EXTRACTED XBRL INSTANCE DOCUMENT fbio-20201231x10k_htm.xml XML 4518897
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
Fortress Biotech, Inc. (Filer) CIK: 0001429260 (see all company filings)

IRS No.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35366 | Film No.: 21793206
SIC: 2834 Pharmaceutical Preparations